Shandong Lukang Pharmaceutical (600789.SH): Injectable Vancomycin Hydrochloride is expected to be selected for the national centralized drug procurement.

Shandong Lukang Pharmaceutical (600789.SH) announced that recently, the company participated in the bidding for the twelfth batch of national centralized drug procurement organized by the National Organization for Drug Centralized Procurement Office. The company's product, injectable vancomycin hydrochloride (0.5g (500,000 units)), is expected to be selected in this centralized procurement. This centralized procurement is the twelfth batch organized by the state, requiring national medical institutions to prioritize the use of selected varieties from the centralized procurement and ensuring completion of the agreed purchasing volume. If the company later signs a procurement contract and implements it, it will be beneficial in expanding sales of related products, increasing market share, enhancing the companys brand influence, and promoting the further development of the companys formulation business.